XML 47 R33.htm IDEA: XBRL DOCUMENT v3.19.2
EQUITY AND NONCONTROLLING INTERESTS (Tables)
6 Months Ended
Jun. 29, 2019
Equity [Abstract]  
Reconciliation of the Numerator and Denominator in the Computations of the Basic and Diluted Earnings Per Share
The following table reconciles the numerator and denominator in the computations of basic and diluted earnings per share:
 
Three Months Ended
 
Six Months Ended
 
June 29, 2019
 
June 30, 2018
 
June 29, 2019
 
June 30, 2018
 
(in thousands)
Numerator:
 
 
 
 
 
 
 
Income from continuing operations, net of income taxes
$
44,309

 
$
52,850

 
$
99,997

 
$
106,118

Income from discontinued operations, net of income taxes

 
1,529

 

 
1,506

Less: Net income attributable to noncontrolling interests
581

 
670

 
1,136

 
1,284

Net income attributable to common shareholders
$
43,728

 
$
53,709

 
$
98,861

 
$
106,340

 
 
 
 
 
 
 
 
Denominator:
 
 
 
 
 
 
 
Weighted-average shares outstanding - Basic
48,772

 
48,198

 
48,615

 
47,992

Effect of dilutive securities:
 
 
 
 
 
 
 
Stock options, restricted stock units, performance share units and restricted stock
890

 
845

 
984

 
974

Weighted-average shares outstanding - Diluted
49,662

 
49,043

 
49,599

 
48,966


Schedule of Accumulated Other Comprehensive Income (Loss)
Changes to each component of accumulated other comprehensive income (loss), net of income taxes, are as follows:
 
Foreign Currency Translation Adjustment
and Other
 
Pension and Other Post-Retirement Benefit Plans
 
Total
 
(in thousands)
December 29, 2018
$
(102,199
)
 
$
(70,504
)
 
$
(172,703
)
Other comprehensive income before reclassifications
6,849

 

 
6,849

Amounts reclassified from accumulated other comprehensive loss

 
748

 
748

Net current period other comprehensive income
6,849

 
748

 
7,597

Income tax expense
961

 
169

 
1,130

June 29, 2019
$
(96,311
)
 
$
(69,925
)
 
$
(166,236
)

Rollforward Redeemable Noncontrolling Interest
The following table provides a rollforward of the activity related to the Company’s redeemable noncontrolling interests:
 
Six Months Ended
 
June 29, 2019
 
June 30, 2018
 
(in thousands)
Beginning balance
$
18,525

 
$
16,609

Adjustment to Vital River redemption value (three months ended March 30, 2019)
1,451

 

Purchase of Vital River 5% equity interest
(8,745
)
 

Change in fair value of Vital River 8% equity interest, included in additional-paid-in-capital
2,708

 

Modification of Vital River 8% purchase option
2,196

 

Acquisition of a 10% non-controlling interest through acquiring Citoxlab
4,095

 

Net income attributable to noncontrolling interests
284

 
377

Foreign currency translation
(35
)
 
(324
)
Ending balance
$
20,479

 
$
16,662